DANAI
LIVE

Serial Number

79393288

Owner

b-rayZ AG

Attorney

Stephen B. Samlan

Filing Date

Feb 8, 2024

Add to watchlist:

No watchlists yet
View on USPTO

DANAI Trademark

Serial Number: 79393288 • Registration: 7734465

DANAI is a trademark filed by b-rayZ AG on February 8, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

b-rayZ AG (4 trademarks)

Wagistrasse 21

Entity Type: 99

Trademark Details

Filing Date

February 8, 2024

Registration Date

March 25, 2025

Published for Opposition

February 4, 2025

Goods & Services

diagnostic apparatus for medical use, namely, cancer diagnostics; testing apparatus for medical use, namely cancer diagnostics; medical imaging apparatus

Scientific research for medical purposes in the field of cancerous diseases; scientific research services for medical purposes in the field of cancerous diseases and medical imaging diagnostics; design and development of software for use in the framework of medical technology; scientific and technological services, namely, computer-aided scientific research, testing and analysis services in the field of cancerous diseases and medical imaging diagnostics; programming of computer software for Internet platforms for others; programming of electronic data processing (EDP) software for others; research relating to the development of computer programs and software; computer software development services; research in the field of artificial intelligence technology

Statistical report analysis and presentation services for business purposes; data processing services; compilation and systematization of information into computer databases; cost-benefit analyses

Medical information services provided via the Internet; medical services in the field of radiology and nuclear medicine; medical diagnostic services, namely, testing and analysis; medical analysis services relating to the treatment of patients; medical analysis services for cancer diagnosis and prognosis; medical testing services for the diagnosis and treatment of persons; medical analysis services relating to the treatment of persons

Computer hardware; downloadable software for digital image processing and medical diagnostics

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 7, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 24, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 6, 2025 FICS
FINAL DISPOSITION PROCESSED
Oct 6, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 27, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 10, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 10, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 26, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 25, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 25, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 4, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 4, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 29, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 14, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 14, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 14, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 14, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 14, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 17, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 17, 2024 TROA
REFUSAL PROCESSED BY IB
Sep 30, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 6, 2024 RFCS
REFUSAL PROCESSED BY MPU
Sep 6, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 6, 2024 RFCR
NON-FINAL ACTION WRITTEN
Sep 5, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 2, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 18, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 12, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 11, 2024 REPR